Single-particle Cryo-EM Principles & Uses

Single-particle cryogenic electron microscopy (cryo-EM) is an analytical technique used to deduce the 3D structure of macromolecules (particularly proteins) as an alternative to X-Ray crystallography. It is not commonly used in quotidian practice but does offer some advantages over other techniques.

Skip to:

Zika virus. Atomic level structure, determined by cryo-EMmolekuul_be | Shutterstock

How does single-particle cryo-EM work?

Pure protein is applied to a grid with very small holes, normally supported by a metal framework. This will ideally evenly distribute the protein molecules throughout these holes in the grid, in varying orientations.

This grid is then snap frozen by immersing in a solution like liquid nitrogen or dry ice. This initially creates a stable snapshot of the protein in various orientations, and also prevents some damage to the protein, as well as averts the evaporation of the buffer.

Images are taken of all the individual proteins in this grid, and then aligned and averaged to create a 3D map. Lots of processing and analysis goes into the final steps of this data, finally producing a 3D model of the protein structure.

What makes cryo-EM special?

Single particle cryo-EM creates a more distinct snapshot of the behavior of a protein at a certain point in time, compared to crystallography where proteins have to form an ordered lattice together before the structure can be determined.

Due to this difference, cryo-EM can potentially give a more accurate insight into the natural form of a protein and provide more information about how it may function.

Allowing the protein to be free-moving up until a snapshot is taken can be a challenge though, as it makes the computational analysis of a protein much more difficult, because many images of the protein in different positions and orientations have to be collated together.

Using single-particle cryo-EM for protein analysis

The determination of the 3D structure of proteins represents the main application of this technique. The other two main methods of deducing protein structure is X-Ray crystallography or nuclear magnetic resonance (NMR).

The process of crystallography can be very unreliable and lengthy. The exact conditions of the protein’s environment have to be found in order for the protein to form a regular lattice. Many screens are, therefore, needed to produce the best quality crystals in order to produce X-Ray diffraction data.

Relatively large amounts of samples are needed for crystallography and NMR compared to single particle cryo-EM. This is a big advantage of cryo-EM, meaning that it can potentially be easier and cheaper in comparison to other methodologies.

Single particle cryo-EM can also be used for all sizes of protein, while NMR has a size restriction for the proteins that can be analyzed. This gives cryo-EM a larger range of options for protein structure analysis.

Advantages

Due to the simple and reliable methodology of single-particle cryo-EM, it is possible to analyze not only simple proteins, but also protein complexes and polymers like F-actin and microtubules, as well as transcription initiation complexes. Many protein complexes only exist for very short amounts of time, and this technique allows them to be visualized.

Other complexes that cryo-EM has enabled close study of are nuclear complexes, where protein binds to DNA or RNA. Many important aspects of cellular machinery rely on these complexes, including during DNA replication and RNA synthesis.

There are many structures in which crystallography cannot determine the structure of, yet single particle cryo-EM can. One example of these are membrane proteins. The transmembrane domain of these proteins needs to be stabilized in solutions by detergents, which can make the crystallization of proteins rather difficult.

Cryo-EM can also determine the structure of proteins with flexible regions without having to remove them, which is often done in crystallography. This cuts out a potentially very difficult step.

Sources

Further Reading

Last Updated: May 2, 2019

Written by

Jack Davis

Jack is a freelance scientific writer with research experience in molecular biology, genetics, human anatomy and physiology, and advanced analytical chemistry. He is also highly knowledgeable about DNA technology, drug analysis, human disease, and biotechnology.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Davis, Jack. (2019, May 02). Single-particle Cryo-EM Principles & Uses. News-Medical. Retrieved on October 31, 2024 from https://www.news-medical.net/life-sciences/Single-particle-Cryo-EM-Principles-Uses.aspx.

  • MLA

    Davis, Jack. "Single-particle Cryo-EM Principles & Uses". News-Medical. 31 October 2024. <https://www.news-medical.net/life-sciences/Single-particle-Cryo-EM-Principles-Uses.aspx>.

  • Chicago

    Davis, Jack. "Single-particle Cryo-EM Principles & Uses". News-Medical. https://www.news-medical.net/life-sciences/Single-particle-Cryo-EM-Principles-Uses.aspx. (accessed October 31, 2024).

  • Harvard

    Davis, Jack. 2019. Single-particle Cryo-EM Principles & Uses. News-Medical, viewed 31 October 2024, https://www.news-medical.net/life-sciences/Single-particle-Cryo-EM-Principles-Uses.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New vaccine strategy targets SARS-CoV-2's stable S2 subunit, offering broad protection against evolving variants